Yevgeniy Brailovsky DO MSc FACC(@YevgeniyBr) 's Twitter Profileg
Yevgeniy Brailovsky DO MSc FACC

@YevgeniyBr

Heart Failure and Heart Transplant Cardiologist @TJUHospital. PH, PE, PV loop, Cardiac Amyloid enthusiast, JACC Case Reports central illustration editor

ID:212491433

calendar_today06-11-2010 06:37:58

4,5K Tweets

2,8K Followers

2,6K Following

Paul Forfia(@PForfiaPHDOC) 's Twitter Profile Photo

Sharing Temple Health Advanced 1Yr / Fellowship in Philadelphia, USA

🏆Apply now‼️by 7/31/24 🗓️ PHFellowshipTemple Health.org
🏆Led by Anjali Vaidya MD 🫀
🏆Join Temple Cardiology Fellowship for ALL PH 🫀🫁, ,🤰PH,

🔗medicine.temple.edu/PH-Fellowship💻

Sharing @TempleHealth Advanced 1Yr #PulmonaryHypertension /#PVD Fellowship in Philadelphia, USA 🏆Apply now‼️by 7/31/24 🗓️ PHFellowship@TempleHealth.org 🏆Led by @anjalivaidyaMD 🏆Join @TempleCards for ALL PH 🫀🫁, #iCPET,🤰PH, #CTEPH 🔗medicine.temple.edu/PH-Fellowship💻
account_circle
Melissa Lyle(@MelissaLyleMD) 's Twitter Profile Photo

How can we detect disease earlier in ATTR carriers? Justin L. Grodin gives an excellent overview on potential ways to look for disease
📌 Circulating TTR and RBP4 may be lower and an early biomarker
📌Subtle difference on imaging
The International Society Of Amyloidosis

How can we detect disease earlier in ATTR carriers? @JLGrodin gives an excellent overview on potential ways to look for #subclinical disease #ISA_2024 #ISA2024 📌 Circulating TTR and RBP4 may be lower and an early biomarker 📌Subtle difference on imaging @ISA_Amyloidosis
account_circle
Dr. Jeffrey Zonder(@Amyloid_Planet) 's Twitter Profile Photo

Ok I’m gonna say it: in clinical practice I feel like the description of the hearts of pts with AL & ATTR in this one slide from an excellent talk by Ahmad Masri is exactly backwards. Thoughts? The International Society Of Amyloidosis

Ok I’m gonna say it: in clinical practice I feel like the description of the hearts of pts with AL & ATTR #amyloidosis in this one slide from an excellent talk by @MasriAhmadMD is exactly backwards. Thoughts? @ISA_Amyloidosis #ISA2024
account_circle
Yevgeniy Brailovsky DO MSc FACC(@YevgeniyBr) 's Twitter Profile Photo

In patients withAL 23% of deaths are classified as “sudden unexplained deaths” at BU Amyloidosis Center. These patients tend to have
⬆️🫀involvement
⬆️ GI involvement
⬆️ autonomic dysfunction
⬆️ dFLC
Thought provoking, can we prevent this?
The International Society Of Amyloidosis Vaishali Sanchorawala

In patients withAL 23% of deaths are classified as “sudden unexplained deaths” at @BU_Amyloidosis. These patients tend to have ⬆️🫀involvement ⬆️ GI involvement ⬆️ autonomic dysfunction ⬆️ dFLC Thought provoking, can we prevent this? @ISA_Amyloidosis #ISA2024 @vsanchorawala
account_circle
Yevgeniy Brailovsky DO MSc FACC(@YevgeniyBr) 's Twitter Profile Photo

Fascinating tidbit from Morie Gertz: Congo red was used to diagnose amyloid. CR rapidly decayed in the blood in patients with amyloid. Fell out of favor by 1960s due to anaphylactic reactions. Mayo Amyloid The International Society Of Amyloidosis

Fascinating tidbit from @MorieGertz: Congo red was used to diagnose amyloid. CR rapidly decayed in the blood in patients with amyloid. Fell out of favor by 1960s due to anaphylactic reactions. @MayoAmyloid @ISA_Amyloidosis #ISA2024
account_circle
BridgeBio Pharma(@BridgeBioPharma) 's Twitter Profile Photo

Join us at the 2024 International Symposium on Amyloidosis! We’ll be sharing updates from our ATTRibute-CM Phase 3 trial in 2 oral presentations & 10 poster presentations & supporting a Satellite Symposium. Learn more about our latest news: bridgebio.com/what-is-attr

account_circle
BridgeBio Pharma(@BridgeBioPharma) 's Twitter Profile Photo

In partnership with Medscape, we launched a medical education tool on the clinical advances in transthyretin amyloid cardiomyopathy (ATTR-CM). We hope this provides supportive resources for physicians to understand the changing landscape of this disease. bit.ly/48ugdnx

In partnership with @Medscape, we launched a medical education tool on the clinical advances in transthyretin amyloid cardiomyopathy (ATTR-CM). We hope this provides supportive resources for physicians to understand the changing landscape of this disease. bit.ly/48ugdnx
account_circle
Michelle Kittleson MD PhD(@MKIttlesonMD) 's Twitter Profile Photo

Should you wake up the patient when you preround?

Not only is there a for that, there's also a piece in this week's NEJM. Check it out :)

nejm.org/doi/full/10.10…

account_circle
JACC Journals(@JACCJournals) 's Twitter Profile Photo

SimPub: In -CA, the baseline 6MWT distance can refine risk stratification beyond traditional prognosticators. Worsening of 6MWT at 1 year was common and independently associated with an increased risk of mortality. bit.ly/44zzYtt

#HeartFailure2024 #JACC SimPub: In #ATTR-CA, the baseline 6MWT distance can refine risk stratification beyond traditional prognosticators. Worsening of 6MWT at 1 year was common and independently associated with an increased risk of mortality. bit.ly/44zzYtt #Amyloidosis
account_circle
BridgeBio Pharma(@BridgeBioPharma) 's Twitter Profile Photo

Excited to share a sub-analysis comparing acoramidis to placebo in Stage 4 chronic kidney disease & results from a pre-specified sensitivity analysis from ATTRibute-CM, our Phase 3 study of acoramidis in ATTR-CM, & 3 posters at @ESCardio Heart Failure. bit.ly/4dE9zPm

Excited to share a sub-analysis comparing acoramidis to placebo in Stage 4 chronic kidney disease & results from a pre-specified sensitivity analysis from ATTRibute-CM, our Phase 3 study of acoramidis in ATTR-CM, & 3 posters at @ESCardio Heart Failure. bit.ly/4dE9zPm
account_circle